1. Adam, B., Malik, G., Yasui, Y., Cazares, L.H., McCarthy, D., Feng, Z., Schellhammer, P.F., Semmes, O.J., Wright, W.J., 2003. Discovery of protein biomarkers for prostate cancer in seminal plasma by SELDI mass spectrometry. Proc. Am. Assoc. Cancer Res. 44, Abstract 6315.
2. Inhibition of constitutive STAT3 activity sensitizes resistant non-Hodgkin’s lymphoma and multiple myeloma to chemotherapeutic drug-mediated apoptosis;Alas;Clin. Cancer Res.,2003
3. Baer, M.R., O’Loughlin, K.L., Minderman, H., 2003. The pipecolinate derivative VX-710 (biricodar; Incel) modulates multidrug resistance (MDR) mediated by P-glycoprotein (Pgp), multidrug resistance protein (MRP-1) and breast cancer resistance protein (BCRP/ABCG2/MXR). Proc. Am. Assoc. Cancer Res. 44, Abstract 589.
4. Balachandran, R., Choy, N., Shin, Y., Nguyen, P.Q., Madiraju, C., Giuliano, K.A., Curran, D.P., Day, B.W., 2003. Synthesis and biological evaluation of simplified discodermolide analogs. Proc. Am. Assoc. Cancer Res. 44, Abstract 455.
5. Banez, L.L., Gao, L., Xu, L., Ali, A., Connelly, R.R., McLeod, D.G., Moul, J.W., Srivastava, S., 2003. p53 Codon 72 Arg single nucleotide polymorphism is associated with prostate cancer. Proc. Am. Assoc. Cancer Res. 44, Abstract 2356.